Most cases (~90%) are driven by the (12;16) (q13;p11) chromosomal translocation that results in the DDIT3-FUS (fused in sarcoma, also known as translocated in sarcoma [TLS]) gene fusion. This evidence concerns the gene FUS and sarcoma.